Extent of cerebellum, subcortical and cortical atrophy in patients with MS. A case-control study

Journal of the Neurological Sciences

Volumn 282, Issue 1-2, 2009, Pages 47-54

  Ramasamy, Deepa Preeti ^a   Benedict, Ralph H B ^b   Cox, Jennifer L ^a,b   Fritz, David ^a   Abdelrahman, Nadir ^a   Hussein, Sara ^a   Minagar, Alireza ^c   Dwyer, Michael G ^a   Zivadinov, Robert ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b JACOBS NEUROLOGICAL INSTITUTE   (United States)

^c Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Cerebellum; Cortical thinning; Deep grey matter; FreeSurfer; Multiple sclerosis

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; BRAIN REGION; BRAIN TISSUE; CEREBELLUM; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; ATROPHY; AUTOMATIC DATA PROCESSING; BRAIN; CASE-CONTROL STUDIES; CEREBELLUM; CEREBRAL CORTEX; DEMYELINATING DISEASES; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NERVE FIBERS, MYELINATED; ORGAN SIZE; SEVERITY OF ILLNESS INDEX; SOFTWARE;

EID: 67349165446     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.12.034     Document Type: Article

References (59)

1. Chard D.T., Griffin C.M., Parker G.J., Kapoor R., Thompson A.J., and Miller D.H. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 125 Pt 2 (2002) 327-337
2. Ge Y., Grossman R.I., Udupa J.K., Babb J.S., Nyul L.G., and Kolson D.L. Brain atrophy in relapsing-remitting multiple sclerosis: fractional volumetric analysis of gray matter and white matter. Radiology 220 3 (2001) 606-610
3. Quarantelli M., Ciarmiello A., Morra V.B., Orefice G., Larobina M., Lanzillo R., et al. Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load. Neuroimage 18 2 (2003) 360-366
4. Pagani E., Rocca M.A., Gallo A., Rovaris M., Martinelli V., Comi G., et al. Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. AJNR Am J Neuroradiol 26 2 (2005) 341-346
5. Horakova D., Cox J.L., Havrdova E., Hussein S., Dolezal O., Cookfair D., et al. Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years. A case control study. J Neurol Neurosurg Psychiatry 79 4 (2008) 407-414
6. Fisher E., Lee J.C., Nakamura K., and Rudick R.A. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 64 3 (2008) 255-265
7. Fisniku L.K., Chard D.T., Jackson J.S., Anderson V.M., Altmann D.R., Miszkiel K.A., et al. Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol 64 3 (2008) 247-254
8. Dalton C.M., Chard D.T., Davies G.R., Miszkiel K.A., Altmann D.R., Fernando K., et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 127 Pt 5 (2004) 1101-1107
9. Valsasina P., Benedetti B., Rovaris M., Sormani M.P., Comi G., and Filippi M. Evidence for progressive gray matter loss in patients with relapsing-remitting MS. Neurology 65 7 (2005) 1126-1128
10. Tiberio M., Chard D.T., Altmann D.R., Davies G., Griffin C.M., Rashid W., et al. Gray and white matter volume changes in early RRMS: a 2-year longitudinal study. Neurology 64 6 (2005) 1001-1007
11. Geurts J.J., Bo L., Roosendaal S.D., Hazes T., Daniels R., Barkhof F., et al. Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 66 9 (2007) 819-827
12. Bo L., Vedeler C.A., Nyland H.I., Trapp B.D., and Mork S.J. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 62 7 (2003) 723-732
13. Charil A., Dagher A., Lerch J.P., Zijdenbos A.P., Worsley K.J., and Evans A.C. Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability. Neuroimage 34 2 (2007) 509-517
14. Kutzelnigg A., Lucchinetti C.F., Stadelmann C., Bruck W., Rauschka H., Bergmann M., et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128 Pt 11 (2005) 2705-2712
15. Vercellino M., Plano F., Votta B., Mutani R., Giordana M.T., and Cavalla P. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 64 12 (2005) 1101-1107
16. Sailer M., Fischl B., Salat D., Tempelmann C., Schonfeld M.A., Busa E., et al. Focal thinning of the cerebral cortex in multiple sclerosis. Brain 126 Pt 8 (2003) 1734-1744
17. Carone D.A., Benedict R.H., Dwyer M.G., Cookfair D.L., Srinivasaraghavan B., Tjoa C.W., et al. Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS. Neuroimage 29 2 (2006) 505-514
18. Simon J.H. Linear and regional measures of brain atrophy in multiple sclerosis. In: Zivadinov R., and Bakshi R. (Eds). Brain and spinal cord atrophy in multiple sclerosis (2004), Nova Biomedical Books, Hauppauge, NY 15-28
19. Zivadinov R., Locatelli L., Stival B., Bratina A., Grop A., Nasuelli D., et al. Normalized regional brain atrophy measurements in multiple sclerosis. Neuroradiology 45 11 (2003) 793-798
20. Locatelli L., Zivadinov R., Grop A., and Zorzon M. Frontal parenchymal atrophy measures in multiple sclerosis. Mult Scler 10 5 (2004) 562-568
21. Benedict R.H., Zivadinov R., Carone D.A., Weinstock-Guttman B., Gaines J., Maggiore C., et al. Regional lobar atrophy predicts memory impairment in multiple sclerosis. AJNR Am J Neuroradiol 26 7 (2005) 1824-1831
22. Tekok-Kilic A., Benedict R.H., Weinstock-Guttman B., Dwyer M.G., Carone D., Srinivasaraghavan B., et al. Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis. Neuroimage (2007)
23. Evangelou N., Konz D., Esiri M.M., Smith S., Palace J., and Matthews P.M. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain 123 Pt 9 (2000) 1845-1849
24. Cifelli A., Arridge M., Jezzard P., Esiri M.M., Palace J., and Matthews P.M. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 52 5 (2002) 650-653
25. Houtchens M.K., Benedict R.H., Killiany R., Sharma J., Jaisani Z., Singh B., et al. Thalamic atrophy and cognition in multiple sclerosis. Neurology 69 12 (2007) 1213-1223
26. Bermel R.A., Innus M.D., Tjoa C.W., and Bakshi R. Selective caudate atrophy in multiple sclerosis: a 3D MRI parcellation study. Neuroreport 14 3 (2003) 335-339
27. Chen J.T., Narayanan S., Collins D.L., Smith S.M., Matthews P.M., and Arnold D.L. Relating neocortical pathology to disability progression in multiple sclerosis using MRI. Neuroimage 23 3 (2004) 1168-1175
28. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33 3 (2002) 341-355
29. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".[see comment]. Ann Neurol 58 6 (2005) 840-846
30. Lublin F.D., and Reingold S.C. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on clinical trials of new agents in multiple sclerosis.[see comment]. Neurology 46 4 (1996) 907-911
31. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 11 (1983) 1444-1452
32. Zivadinov R., Sepcic J., Nasuelli D., De Masi R., Bragadin L.M., Tommasi M.A., et al. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 70 6 (2001) 773-780
33. Dale A.M., Fischl B., and Sereno M.I. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9 2 (1999) 179-194
34. Fischl B., Sereno M.I., and Dale A.M. Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system. Neuroimage 9 2 (1999) 195-207
35. Fischl B., and Dale A.M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 97 20 (2000) 11050-11055
36. Benedict R., Bruce J., Dwyer M., Abderlahman N., and Zivadinov R. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Arch Neurol 63 9 (2006) 1301-1306
37. De Stefano N., Matthews P.M., Filippi M., Agosta F., De Luca M., Bartolozzi M.L., et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 60 7 (2003) 1157-1162
38. Davie C.A., Barker G.J., Webb S., Tofts P.S., Thompson A.J., Harding A.E., et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss.[see comment][erratum appears in Brain 1996 Aug;119 (Pt 4): 1415]. Brain 118 Pt 6 (1995) 1583-1592
39. Edwards S.G., Gong Q.Y., Liu C., Zvartau M.E., Jaspan T., Roberts N., et al. Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis. Brain 122 Pt 2 (1999) 291-301
40. Paulesu E., Perani D., Fazio F., Comi G., Pozzilli C., Martinelli V., et al. Functional basis of memory impairment in multiple sclerosis: a[18F]FDG PET study. Neuroimage 4 2 (1996) 87-96
41. Brex P.A., Jenkins R., Fox N.C., Crum W.R., O J.I., Riordan, Plant G.T., et al. Detection of ventricular enlargement in patients at the earliest clinical stage of MS. Neurology 54 8 (2000) 1689-1691
42. Bakshi R., Benedict R.H., Bermel R.A., Caruthers S.D., Puli S.R., Tjoa C.W., et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 59 1 (2002) 62-68
43. Bakshi R., Dmochowski J., Shaikh Z.A., and Jacobs L. Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients.[see comment]. J Neurol Sci 185 1 (2001) 19-26
44. Bakshi R., Shaikh Z.A., and Janardhan V. MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation. Neuroreport 11 1 (2000) 15-21
45. Kidd D., Barkhof F., McConnell R., Algra P.R., Allen I.V., and Revesz T. Cortical lesions in multiple sclerosis. Brain 122 Pt 1 (1999) 17-26
46. Geurts J.J., Pouwels P.J., Uitdehaag B.M., Polman C.H., Barkhof F., and Castelijns J.A. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 236 1 (2005) 254-260
47. Geurts J.J., Bo L., Pouwels P.J., Castelijns J.A., Polman C.H., and Barkhof F. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. Ajnr: Am J Neuroradiol 26 3 (2005) 572-577
48. Pirko I., Lucchinetti C.F., Sriram S., and Bakshi R. Gray matter involvement in multiple sclerosis.[see comment]. Neurology 68 9 (2007) 634-642
49. Geurts J.J., Reuling I.E., Vrenken H., Uitdehaag B.M., Polman C.H., Castelijns J.A., et al. MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis. Magn Reson Med 55 3 (2006) 478-483
50. Sicotte N.L., Kern K.C., Giesser B.S., Arshanapalli A., Schultz A., Montag M., et al. Regional hippocampal atrophy in multiple sclerosis. Brain 131 Pt 4 (2008) 1134-1141
51. Han X., Jovicich J., Salat D., van der Kouwe A., Quinn B., Czanner S., et al. Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage 32 1 (2006) 180-194
52. Rosas H.D., Liu A.K., Hersch S., Glessner M., Ferrante R.J., Salat D.H., et al. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 58 5 (2002) 695-701
53. Kuperberg G.R., Broome M.R., McGuire P.K., David A.S., Eddy M., Ozawa F., et al. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry 60 9 (2003) 878-888
54. Salat D.H., Buckner R.L., Snyder A.Z., Greve D.N., Desikan R.S., Busa E., et al. Thinning of the cerebral cortex in aging. Cereb Cortex 14 7 (2004) 721-730
55. Barkhof F. MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS). Mult Scler 5 4 (1999) 283-286
56. Fabiano A.J., Sharma J., Weinstock-Guttman B., Munschauer III F.E., Benedict R.H., Zivadinov R., et al. Thalamic involvement in multiple sclerosis: a diffusion-weighted magnetic resonance imaging study.[see comment]. J Neuroimaging 13 4 (2003) 307-314
57. Benedict R.H., Ramasamy D., Munschauer F., Weinstock-Guttman B., and Zivadinov R. Memory impairment in multiple sclerosis: correlation with deep gray matter and mesial temporal atrophy. J Neurol Neurosurg Psychiatry (2008)
58. Calabrese M., Atzori M., Bernardi V., Morra A., Romualdi C., Rinaldi L., et al. Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 254 9 (2007) 1212-1220
59. Thompson A.J., Montalban X., Barkhof F., Brochet B., Filippi M., Miller D.H., et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 47 6 (2000) 831-835